January 18, 2008 — Researchers are unveiling a new virus in a report published online January 17 in Science. Dubbed the Merkel cell polyomavirus, it is the first to be strongly associated with a human ...

A scientist whose discoveries about prostate cancer have led to lifesaving treatments is now shedding light on an emerging and deadlier form of the disease: neuroendocrine prostate cancer (NEPC). Most ...

A leading scientist whose discoveries about prostate cancer led to lifesaving treatments is now shedding light on an emerging and deadlier form of the disease: neuroendocrine prostate cancer (NEPC).

Neuroendocrine cancer is one of the rarest types, which begins with special hormone-making cells scattered through the body, and it was the tumor with which Irrfan Khan was diagnosed back in 2018.

A phase 1 trial combines immunotherapy and an oncolytic virus for high-grade neuroendocrine tumors, aiming to enroll 36 patients by 2030. The trial evaluates Opdivo, Yervoy, and Seneca Valley ...

PNETs are classified as functional or non-functional, influencing symptoms and treatment strategies. Tumor grade impacts prognosis and treatment plans. Diagnosis involves imaging, blood tests, and ...

Symptoms of neuroendocrine tumors (NETs) can vary depending on their location and severity. General symptoms include extreme fatigue, unexplained weight loss, and loss of appetite. NETs are a rare ...

Multiple endocrine neoplasia type 2 is a rare genetic disorder that causes tumors in the thyroid, parathyroid, and adrenal glands. Multiple endocrine neoplasia type 2 (MEN2) is one of several types of ...

MSK physician-scientist Dr. Charles Sawyers has developed a powerful new research tool for understanding how the most common form of prostate cancer transforms into a lethal type. A leading scientist ...